Overview
Dermatoleukodystrophy is an extremely rare genetic condition that affects both the skin and the brain's white matter. The name comes from 'dermato' (skin), 'leuko' (white), and 'dystrophy' (abnormal development), reflecting the two main areas of the body that are involved. This condition falls under the broader category of leukodystrophies, which are disorders that damage the myelin sheath — the protective covering around nerve fibers in the brain. It is also classified under lipid storage disorders (ICD-10 code E75.2), suggesting problems with how the body processes certain fats. Patients with dermatoleukodystrophy typically show skin abnormalities such as thickened, dry, or scaly skin (similar to ichthyosis), along with progressive neurological problems. These neurological issues can include intellectual disability, developmental delays, movement difficulties, and sometimes seizures. The skin findings may be present from birth or early childhood, while the neurological symptoms can worsen over time as the white matter of the brain deteriorates. Because this condition is so rare, there is currently no specific cure or targeted treatment. Management focuses on supportive care, including skin treatments to manage dryness and scaling, physical and occupational therapy for movement difficulties, anti-seizure medications if needed, and educational support for developmental delays. Research into the underlying genetic and metabolic causes continues, but treatment options remain limited.
Also known as:
Key symptoms:
Thick, dry, or scaly skinIntellectual disabilityDevelopmental delaysDifficulty with movement and coordinationSeizuresProgressive loss of brain white matterShort stature or growth problemsMuscle stiffness or spasticitySpeech and language delaysVision problemsAbnormal facial features
Clinical phenotype terms (6)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Dermatoleukodystrophy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Dermatoleukodystrophy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Dermatoleukodystrophy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Dermatoleukodystrophy.
Community
No community posts yet. Be the first to share your experience with Dermatoleukodystrophy.
Start the conversation →Latest news about Dermatoleukodystrophy
No recent news articles for Dermatoleukodystrophy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the expected progression of this condition for my child specifically?,What therapies and interventions should we start right away?,Are there any clinical trials or research studies we could participate in?,How often should brain MRI scans be repeated to monitor the white matter changes?,What skin care routine do you recommend to best manage the skin symptoms?,Should we pursue genetic testing for other family members to understand carrier status?,What emergency signs should we watch for, and what is the plan if seizures occur?
Common questions about Dermatoleukodystrophy
What is Dermatoleukodystrophy?
Dermatoleukodystrophy is an extremely rare genetic condition that affects both the skin and the brain's white matter. The name comes from 'dermato' (skin), 'leuko' (white), and 'dystrophy' (abnormal development), reflecting the two main areas of the body that are involved. This condition falls under the broader category of leukodystrophies, which are disorders that damage the myelin sheath — the protective covering around nerve fibers in the brain. It is also classified under lipid storage disorders (ICD-10 code E75.2), suggesting problems with how the body processes certain fats. Patients wi
How is Dermatoleukodystrophy inherited?
Dermatoleukodystrophy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Dermatoleukodystrophy typically begin?
Typical onset of Dermatoleukodystrophy is infantile. Age of onset can vary across affected individuals.